Emerging treatment approaches for COVID-19 infection: a critical review

A Bharadwaj, R Kaur, S Gupta - Current Molecular Medicine, 2024 - ingentaconnect.com
Current Molecular Medicine, 2024ingentaconnect.com
In the present scenario, the SARS-CoV-2 virus has imposed enormous damage on human
survival and the global financial system. It has been estimated that around 111 million
people all around the world have been infected, and about 2.47 million people died due to
this pandemic. The major symptoms were sneezing, coughing, cold, difficulty breathing,
pneumonia, and multi-organ failure associated 1with SARS-CoV-2. Currently, two key
problems, namely insufficient attempts to develop drugs against SARSCoV-2 and the lack of …
In the present scenario, the SARS-CoV-2 virus has imposed enormous damage on human survival and the global financial system. It has been estimated that around 111 million people all around the world have been infected, and about 2.47 million people died due to this pandemic. The major symptoms were sneezing, coughing, cold, difficulty breathing, pneumonia, and multi-organ failure associated 1with SARS-CoV-2. Currently, two key problems, namely insufficient attempts to develop drugs against SARSCoV-2 and the lack of any biological regulating process, are mostly responsible for the havoc caused by this virus. Henceforth, developing a few novel drugs is urgently required to cure this pandemic. It has been noticed that the pathogenesis of COVID-19 is caused by two main events: infection and immune deficiency, that occur during the pathological process. Antiviral medication can treat both the virus and the host cells. Therefore, in the present review, the major approaches for the treatment have been divided into
ingentaconnect.com
以上显示的是最相近的搜索结果。 查看全部搜索结果